Epigenetic Modifiers
Epigenetic Modifiers is a class of antineoplastic agents that mediate changes in gene expression through reversible chemical modifications of DNA or histone proteins without altering the underlying nucleotide sequence.
763
Publications
39.8K
Citations
5.8K
Authors
1.6K
Institutions
Publications per year
2017–2026
396
Variants
Epigenetic DrugsEpigenetic Modifying Agents
Parents
763
Ian C.G. Weaver, Ana C. D’Alessio, Shelley E. Brown et al. · Journal of Neuroscience · 2007 · 507 citations · Full text
Medicine, Neurobiology, Neuroscience +16
1–5 of 763
5.8K
5
h-index
4
h-index
National Agricultural Research Foundation, Greece
4 publications · 248 citations
4
h-index
4
h-index
4
h-index
1–5 of 5.8K
1.6K
Heidelberg University
Heidelberg, Germany
15 h-index
63 publications
2.9K citations
Inserm
Paris, France
14 h-index
56 publications
3.6K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
14 h-index
95 publications
6.1K citations
National Institutes of Health
Bethesda, United States
14 h-index
36 publications
3.9K citations

Howard Hughes Medical Institute
Chevy Chase, United States
14 h-index
22 publications
2.2K citations
Memorial Sloan Kettering Cancer Center
New York, United States
14 h-index
52 publications
6.3K citations

Centre National de la Recherche Scientifique
Paris, France
13 h-index
49 publications
2.1K citations
German Cancer Research Center
Heidelberg, Germany
13 h-index
50 publications
2.3K citations
1–8 of 1.6K
33 publications · 1.2K citations
23
h-index
18 publications · 1.2K citations
16
h-index
17 publications · 633 citations
16
h-index
Repository · 23 publications · 762 citations
15
h-index
16 publications · 661 citations
15
h-index
1–5